Continuous Production of Influenza VLPs Using IC‐BEVS and Multi‐Stage Bioreactors

IF 3.5 2区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Biotechnology and Bioengineering Pub Date : 2025-01-18 DOI:10.1002/bit.28925
Ricardo Correia, Taja Zotler, Francisco Ferraz, Bárbara Fernandes, Miguel Graça, Gorben P. Pijlman, Paula M. Alves, António Roldão
{"title":"Continuous Production of Influenza VLPs Using IC‐BEVS and Multi‐Stage Bioreactors","authors":"Ricardo Correia, Taja Zotler, Francisco Ferraz, Bárbara Fernandes, Miguel Graça, Gorben P. Pijlman, Paula M. Alves, António Roldão","doi":"10.1002/bit.28925","DOIUrl":null,"url":null,"abstract":"The insect cell‐baculovirus expression vector system (IC‐BEVS) has been an asset to produce biologics for over 30 years. With the current trend in biotechnology shifting toward process intensification and integration, developing intensified processes such as continuous production is crucial to hold this platform as a suitable alternative to others. However, the implementation of continuous production has been hindered by the lytic nature of this expression system and the process‐detrimental virus passage effect. In this study, we implemented a multi‐stage bioreactor setup for continuous production of influenza hemagglutinin‐displaying virus‐like particles (HA‐VLPs) using IC‐BEVS. A setup consisting of one Cell Growth Bioreactor simultaneously feeding non‐infected insect cells to three parallel Production Bioreactors operated at different residence times (RT) (18, 36, and 54 h) was implemented; Production Bioreactors were continuously harvested. Two insect cell lines (neutral pH–adapted High Five and <jats:italic>Sf</jats:italic>9) and two recombinant baculovirus (rBAC) constructs (one that originates from a bacmid, rBAC<jats:sub>bacmid</jats:sub>, and another of non‐bacteria origin, rBAC<jats:sub>flashbac</jats:sub>) were tested. Combining rBAC<jats:sub>flashbac</jats:sub> with <jats:italic>Sf</jats:italic>9 cells was the most efficient approach, allowing consistent HA‐VLPs titers (34 ± 14 HA titer/mL) and rBAC titers (10<jats:sup>8</jats:sup>–10<jats:sup>9</jats:sup> pfu/mL) throughout the period of continuous operation (20 days). Cell growth kinetics and viability varied across RT, and higher RT was associated with increased expression of HA‐VLPs, independent of the cell line and rBAC used; RT of 54 h allowed to maximize titers. The presence of particles resembling HA‐VLPs was confirmed by transmission electron microscopy throughout the continuous operation. This work showcases the implementation of a process for continuous production of a promising class of biotherapeutics (i.e., VLPs), and paves the way for establishing continuous, integrated setups using the IC‐BEVS expression system.","PeriodicalId":9168,"journal":{"name":"Biotechnology and Bioengineering","volume":"56 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology and Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/bit.28925","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The insect cell‐baculovirus expression vector system (IC‐BEVS) has been an asset to produce biologics for over 30 years. With the current trend in biotechnology shifting toward process intensification and integration, developing intensified processes such as continuous production is crucial to hold this platform as a suitable alternative to others. However, the implementation of continuous production has been hindered by the lytic nature of this expression system and the process‐detrimental virus passage effect. In this study, we implemented a multi‐stage bioreactor setup for continuous production of influenza hemagglutinin‐displaying virus‐like particles (HA‐VLPs) using IC‐BEVS. A setup consisting of one Cell Growth Bioreactor simultaneously feeding non‐infected insect cells to three parallel Production Bioreactors operated at different residence times (RT) (18, 36, and 54 h) was implemented; Production Bioreactors were continuously harvested. Two insect cell lines (neutral pH–adapted High Five and Sf9) and two recombinant baculovirus (rBAC) constructs (one that originates from a bacmid, rBACbacmid, and another of non‐bacteria origin, rBACflashbac) were tested. Combining rBACflashbac with Sf9 cells was the most efficient approach, allowing consistent HA‐VLPs titers (34 ± 14 HA titer/mL) and rBAC titers (108–109 pfu/mL) throughout the period of continuous operation (20 days). Cell growth kinetics and viability varied across RT, and higher RT was associated with increased expression of HA‐VLPs, independent of the cell line and rBAC used; RT of 54 h allowed to maximize titers. The presence of particles resembling HA‐VLPs was confirmed by transmission electron microscopy throughout the continuous operation. This work showcases the implementation of a process for continuous production of a promising class of biotherapeutics (i.e., VLPs), and paves the way for establishing continuous, integrated setups using the IC‐BEVS expression system.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用IC - BEVS和多级生物反应器连续生产流感病毒VLPs
昆虫细胞-杆状病毒表达载体系统(IC - BEVS)在生物制剂生产领域已经有30多年的历史。随着目前生物技术的趋势转向过程集约化和集成化,开发集约化的过程,如连续生产,对于使该平台成为其他平台的合适替代方案至关重要。然而,该表达系统的裂解性质和过程有害的病毒传代效应阻碍了连续生产的实现。在这项研究中,我们实施了一个多级生物反应器设置,用于使用IC - BEVS连续生产显示流感血凝素的病毒样颗粒(HA - VLPs)。实验设置了一个细胞生长生物反应器,同时将未感染的昆虫细胞送入三个平行的生产生物反应器,分别在不同的停留时间(RT)(18、36和54 h)运行;生产生物反应器连续收获。测试了两种昆虫细胞系(中性ph适应性High Five和Sf9)和两种重组杆状病毒(rBAC)构建物(一种源自bacmid, rBACbacmid,另一种源自非细菌,rBACflashbac)。rBACflashbac与Sf9细胞结合是最有效的方法,在连续操作(20天)期间,HA - VLPs滴度(34±14 HA滴度/mL)和rBAC滴度(108-109 pfu/mL)保持一致。细胞生长动力学和活力在不同的RT中有所不同,较高的RT与HA - VLPs的表达增加有关,与细胞系和rBAC无关;54 h的RT可使滴度达到最大。在整个连续操作过程中,透射电镜证实了类似HA - VLPs的粒子的存在。这项工作展示了一种有前途的生物治疗药物(即VLPs)的连续生产过程的实施,并为使用IC‐BEVS表达系统建立连续的集成设置铺平了道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Biotechnology and Bioengineering
Biotechnology and Bioengineering 工程技术-生物工程与应用微生物
CiteScore
7.90
自引率
5.30%
发文量
280
审稿时长
2.1 months
期刊介绍: Biotechnology & Bioengineering publishes Perspectives, Articles, Reviews, Mini-Reviews, and Communications to the Editor that embrace all aspects of biotechnology. These include: -Enzyme systems and their applications, including enzyme reactors, purification, and applied aspects of protein engineering -Animal-cell biotechnology, including media development -Applied aspects of cellular physiology, metabolism, and energetics -Biocatalysis and applied enzymology, including enzyme reactors, protein engineering, and nanobiotechnology -Biothermodynamics -Biofuels, including biomass and renewable resource engineering -Biomaterials, including delivery systems and materials for tissue engineering -Bioprocess engineering, including kinetics and modeling of biological systems, transport phenomena in bioreactors, bioreactor design, monitoring, and control -Biosensors and instrumentation -Computational and systems biology, including bioinformatics and genomic/proteomic studies -Environmental biotechnology, including biofilms, algal systems, and bioremediation -Metabolic and cellular engineering -Plant-cell biotechnology -Spectroscopic and other analytical techniques for biotechnological applications -Synthetic biology -Tissue engineering, stem-cell bioengineering, regenerative medicine, gene therapy and delivery systems The editors will consider papers for publication based on novelty, their immediate or future impact on biotechnological processes, and their contribution to the advancement of biochemical engineering science. Submission of papers dealing with routine aspects of bioprocessing, description of established equipment, and routine applications of established methodologies (e.g., control strategies, modeling, experimental methods) is discouraged. Theoretical papers will be judged based on the novelty of the approach and their potential impact, or on their novel capability to predict and elucidate experimental observations.
期刊最新文献
Derivation of an Upscaled Model for Xylitol Production With Immobilized Microorganisms Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale Zeolitic Imidazole Framework-8 Nanoparticles as an Alternative to Freund's Adjuvant for Klebsiella pneumoniae Recombinant Protein Vaccine Biotechnology and Bioengineering: Volume 122, Number 3, March 2025 Enhanced Natural Killer Cell Proliferation by Stress-Induced Feeder Cells
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1